Mucosal microbiome dysbiosis in gastric carcinogenesis

Gut

Volumn 67, Issue 6, 2018, Pages 1024-1032

  Coker, Olabisi Oluwabukola ^a   Dai, Zhenwei ^a   Nie, Yongzhan ^b   Zhao, Guijun ^c   Cao, Lei ^a   Nakatsu, Geicho ^a   Wu, William Kk ^a   Wong, Sunny Hei ^a   Chen, Zigui ^d   Sung, Joseph J Y ^a   Yu, Jun ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c INNER MONGOLIA PEOPLE S HOSPITAL   (China)

^d Prince of Wales Hospital   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

RNA 16S;

16S RRNA GENE; AREA UNDER THE CURVE; ARTICLE; ATROPHIC GASTRITIS; BACTERIAL TRANSMISSION; BACTERIUM; BACTERIUM IDENTIFICATION; CANCER GROWTH; CANCER STAGING; CHINA; COHORT ANALYSIS; CONTROLLED STUDY; CORIOBACTERIACEAE; DIALISTER PNEUMOSINTES; DISEASE ASSOCIATION; DNA BASE COMPOSITION; DYSBIOSIS; GASTRITIS; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MICROBIOME; NONHUMAN; PARVIMONAS MICRA; PEPTOSTREPTOCOCCACEAE; PEPTOSTREPTOCOCCUS STOMATIS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SLACKIA EXIGUA; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH MUCOSA; STREPTOCOCCUS ANGINOSUS; SUPERFICIAL GASTRITIS; TAXONOMIC IDENTIFICATION; VALIDATION PROCESS; VEILLONELLACEAE; ADULT; AGED; CARCINOGENESIS; CELL TRANSFORMATION; FEMALE; GENETICS; MALE; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; PATHOLOGY; STOMACH; STOMACH TUMOR; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CARCINOGENESIS; CELL TRANSFORMATION, NEOPLASTIC; CHINA; DYSBIOSIS; FEMALE; GASTRIC MUCOSA; HUMANS; MALE; MICROBIOTA; MIDDLE AGED; RNA, RIBOSOMAL, 16S; STOMACH; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 85048754113     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2017-314281     Document Type: Article

References (52)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA: A Cancer Journal for Clinicians 2016;66:7-30.
2. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-first American Cancer society award lecture on Cancer epidemiology and Prevention. Cancer Res 1992;52:6735-40.
3. Compare D, Rocco A, Nardone G. Risk factors in gastric Cancer. Eur Rev Med Pharmacol Sci 2010;14:302-8.
4. Nardone G, Compare D. The human gastric Microbiota: is it time to rethink the pathogenesis of stomach diseases? United European Gastroenterol J 2015;3:255-60.
5. Aviles-Jimenez F, Vazquez-Jimenez F, Medrano-Guzman R, et al. Stomach Microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric Cancer. Sci Rep 2014;4:4202.
6. Eun CS, Kim BK, Han DS, et al. Differences in gastric mucosal Microbiota profiling in patients with chronic gastritis, intestinal metaplasia, and gastric Cancer using pyrosequencing methods. Helicobacter 2014;19:407-16.
7. Dicksved J, Lindberg M, Rosenquist M, et al. Molecular characterization of the stomach Microbiota in patients with gastric Cancer and in controls. J Med Microbiol 2009;58:509-16.
8. Peek RM, Crabtree JE. Helicobacter infection and gastric neoplasia. J Pathol 2006;208:233-48.
9. Lofgren JL, Whary MT, Ge Z, et al. Lack of commensal flora in Helicobacter pyloriinfected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia. Gastroenterology 2011;140:210-20.
10. Lee CW, Rickman B, Rogers AB, et al. Combination of sulindac and antimicrobial eradication of Helicobacter pylori prevents progression of gastric Cancer in hypergastrinemic INS-GAS mice. Cancer Res 2009;69:8166-74.
11. Zheng YS, Chen ZL, Sai XY, et al. Cross-sectional analysis of Helicobacter pylori infection in physical examination population. Chinese journal of clinical medicine 2013;7:100444-10047.
12. Jw Y, Hj A, Su H, et al. Analysis of infestation rate of Helicobacter pylori and factors affcecting the infestation in inner Mongolia border recruits. Med J Chn PLA 2014;39:760-3.
13. Schloss PD, Westcott SL, Ryabin T, et al. Introducing mothur: open-source, platformindependent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 2009;75:7537-41.
14. Pruesse E, Peplies J, Glöckner FO. SINA: accurate high-throughput multiple sequence alignment of ribosomal RNA genes. Bioinformatics 2012;28:1823-9.
15. Edgar RC, Haas BJ, Clemente JC, et al. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 2011;27:2194-200.
16. Kim J, Kim N, Jo HJ, Hj J, et al. An Appropriate Cutoff Value for determining the colonization of Helicobacter pylori by the Pyrosequencing Method: Comparison with Conventional Methods. Helicobacter 2015;20:370-80.
17. Zhu L, Li L, Li R, et al. Model-Free Feature Screening for Ultrahigh Dimensional Data. J Am Stat Assoc 2011;106:1464-75.
18. Li J, Zhong W, Li R, et al. A fast algorithm for detecting gene-gene interactions in genome-wide association studies. Ann Appl Stat 2014;8:2292-318.
19. Luo X, Stefanski LA, Boos DD. Tuning variable selection procedures by adding noise. Technometrics 2006;48:165-75.
20. Yj W, Boos DD, Stefanski LA. Controlling variable selection by the addition of pseudovariables. J Am Stat Assoc 2007;102:235-43.
21. Chen T, Wh Y, Izard J, et al. The Human Oral Microbiome Database: a web Accessible resource for investigating Oral microbe Taxonomic and Genomic information. Database;2010;2010. baq013.
22. Friedman J, Alm EJ. Inferring correlation networks from genomic survey data. PLoS Comput Biol 2012;8:e1002687.
23. Azuaje FJ. Selecting biologically informative genes in co-expression networks with a centrality score. Biol Direct 2014;9:12.
24. Langille MG, Zaneveld J, Caporaso JG, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol 2013;31:814-21.
25. Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011;12:r60.
26. by the FUT2 crohn's disease risk polymorphism. Isme J 2014;8:2193-206.
27. Yoneda M, Suzuki N, et al. Oral Bacteria and bowel diseases - Mini Review. J Gastrointest Dig Syst 2016;06:404.
28. Michaud DS. Role of bacterial infections in pancreatic Cancer. Carcinogenesis 2013;34:2193-7.
29. Nakatsu G, Li X, Zhou H, et al. Gut mucosal microbiome across stages of colorectal carcinogenesis. Nat Commun 2015;6:8727.
30. Niccoli AA, Artesi AL, Candio F, et al. Preliminary results on clinical effects of probiotic Lactobacillus salivarius LS01 in children affected by atopic dermatitis. J Clin Gastroenterol 2014;48 Suppl 1:S34-S36.
31. Archer AC , Halami PM. Probiotic attributes of Lactobacillus fermentum isolated from human feces and dairy products. Appl Microbiol Biotechnol 2015;99:8113-23.
32. Kienesberger S, Cox LM, Livanos A, et al. Gastric Helicobacter pylori infection affects local and distant microbial populations and Host responses. Cell Rep 2016;14:1395-407.
33. Bik EM, Eckburg PB, Gill SR, et al. Molecular analysis of the bacterial Microbiota in the human stomach. Proc Natl Acad Sci U S A 2006;103:732-7.
34. Carding S, Verbeke K, Vipond DT, et al. Dysbiosis of the gut Microbiota in disease. Microbial Ecology in Health & Disease 2015;26:26191.
35. Yang I, Woltemate S, Piazuelo MB, et al. Different gastric Microbiota compositions in two human populations with high and low gastric Cancer risk in Colombia. Sci Rep 2016;6:18594.
36. Haro C, Rangel-Zúñiga OA, Alcalá-Díaz JF, et al. Intestinal Microbiota is Influenced by gender and body Mass Index. PLoS One 2016;11:e0154090.
37. Conlon MA, Bird AR. The impact of diet and lifestyle on gut Microbiota and human health. Nutrients 2014;7:17-44.
38. Sasaki H, Ishizuka T, Muto M, et al. Presence of Streptococcus anginosus DNA in esophageal Cancer, dysplasia of esophagus, and gastric Cancer. Cancer Res 1998;58:2991-5.
39. Morita E, Narikiyo M, Yano A, et al. Different frequencies of Streptococcus anginosus infection in oral Cancer and esophageal Cancer. Cancer Sci 2003;94:492-6.
40. Takahashi Y, Yoshida A, Nagata E, et al. Streptococcus anginosus l-cysteine desulfhydrase gene expression is associated with abscess formation in BALB/c mice. Mol Oral Microbiol 2011;26:221-7.
41. Kilian M, Chapple IL, Hannig M, et al. The oral microbiome - an update for oral healthcare professionals. Br Dent J 2016;221:657-66.
42. Yin X-H, Wang Y-D, Luo H, et al. Association between Tooth loss and gastric Cancer: a Meta-Analysis of Observational Studies. PLoS One 2016;11:e0149653.
43. Fan X, Alekseyenko AV, Wu J, et al. Human oral microbiome and prospective risk for pancreatic Cancer: a population-based nested case-control study. Gut 2018;67:120-7.
44. Dejea CM, Wick EC, Hechenbleikner EM, et al. Microbiota organization is a distinct feature of proximal colorectal cancers. Proc Natl Acad Sci U S A 2014;111:18321-6.
45. Johnson CH, Dejea CM, Edler D, et al. Metabolism links bacterial biofilms and Colon carcinogenesis. Cell Metab 2015;21:891-7.
46. Ekström AM, Held M, Hansson LE, et al. Helicobacter pylori in gastric Cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 2001;121:784-91.
47. Schulz C, Schütte K, Koch N, et al. The active bacterial assemblages of the upper GI tract in individuals with and without Helicobacter infection. Gut 2018;67:216-25.
48. Di Virgilio F, Purines DVF. Purines, purinergic receptors, and Cancer. Cancer Res 2012;72:5441-7.
49. Wong JM, de Souza R, Kendall CW, et al. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 2006;40:235-43.
50. Belcheva A, Irrazabal T, Robertson SJ, et al. Gut microbial metabolism drives transformation of MSH2-deficient Colon epithelial cells. Cell 2014;158:288-99.
51. Kaakoush NO, Morris MJ. The oesophageal microbiome: an unexplored link in obesityassociated oesophageal adenocarcinoma. FEMS Microbiol Ecol 2016;92:fiw161.
52. Grivennikov SI, Wang K, Mucida D, et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 2012;491:254-8.